Bliss GVS Pharma
BLISSGVS.NS
#8268
Rank
NZ$0.27 B
Marketcap
$2.61
Share price
6.96%
Change (1 day)
-5.17%
Change (1 year)

Earnings for Bliss GVS Pharma (BLISSGVS.NS)

Earnings in 2024 (TTM): NZ$20.97 Million

According to Bliss GVS Pharma's latest financial reports the company's current earnings are NZ$95.38 Million. In 2023 the company made an earning of NZ$25.29 Million a decrease over its 2022 earnings that were of NZ$29.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bliss GVS Pharma from 2016 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$20.97 M-17.08%
2023 NZ$25.29 M-14.28%
2022 NZ$29.51 M163.23%
2021 NZ$11.21 M-50.11%
2020 NZ$22.47 M-38.94%
2019 NZ$36.8 M10.3%
2018 NZ$33.36 M-45.47%
2017 NZ$61.18 M35.61%
2016 NZ$45.12 M